Balance Sheet
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEV to RevenueEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to EarningsPrice to Sales
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInventory AverageInvested Capital

Cellebrite DI (CLBT) Enterprise Value (2020 - 2025)

Cellebrite DI has reported Enterprise Value over the past 5 years, most recently at -$285.5 million for Q4 2025.

  • Quarterly results put Enterprise Value at -$285.5 million for Q4 2025, up 17.34% from a year ago — trailing twelve months through Dec 2025 was -$285.5 million (up 17.34% YoY), and the annual figure for FY2025 was -$285.5 million, up 17.34%.
  • Enterprise Value for Q4 2025 was -$285.5 million at Cellebrite DI, up from -$345.4 million in the prior quarter.
  • Over the last five years, Enterprise Value for CLBT hit a ceiling of -$132.3 million in Q4 2022 and a floor of -$345.4 million in Q4 2024.
  • Median Enterprise Value over the past 4 years was -$256.9 million (2023), compared with a mean of -$247.9 million.
  • Biggest five-year swings in Enterprise Value: tumbled 72.51% in 2023 and later increased 17.34% in 2025.
  • Cellebrite DI's Enterprise Value stood at -$132.3 million in 2022, then plummeted by 72.51% to -$228.2 million in 2023, then crashed by 51.35% to -$345.4 million in 2024, then increased by 17.34% to -$285.5 million in 2025.
  • The last three reported values for Enterprise Value were -$285.5 million (Q4 2025), -$345.4 million (Q4 2024), and -$228.2 million (Q4 2023) per Business Quant data.